- August 18, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Jeuveau, prabotulinumtoxinA-xvfs
Synonyms :
Class :
Anticholinergics and ganglionic blocking agents
Dosage Forms & Strengths
Injection- powder for reconstitution
100units for single-dose vial
Safety and efficacy not established
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the neuromuscular adverse effect of corticosteroids
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the arrhythmogenic effect of cardiac glycosides
may enhance the arrhythmogenic effect of cardiac glycosides
may enhance the arrhythmogenic effect of cardiac glycosides
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents